<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE347nnn/GSE347263/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Methylation profiling</omics_type><species>Homo sapiens</species><gds_type>Methylation profiling by genome tiling array</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE347263</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Decitabine-induced CD38 upregulation augments daratumumab activity in xenograft T-ALL</name><description>This study investigates epigenetic regulation of CD38 in T-cell acute lymphoblastic leukemia (T-ALL) and the effect of decitabine (DEC) on CD38 promoter methylation and CD38 expression. Genome-wide DNA methylation profiling was performed in T-ALL cell lines treated with DEC or DMSO and in baseline T-ALL patient-derived xenograft (PDX) samples using the Illumina Infinium MethylationEPIC BeadChip v2.0.</description><dates><publication>2026/09/15</publication></dates><accession>GSE347263</accession><cross_references><GSM>GSM10048123</GSM><GSM>GSM10048112</GSM><GSM>GSM10048124</GSM><GSM>GSM10048113</GSM><GSM>GSM10048121</GSM><GSM>GSM10048110</GSM><GSM>GSM10048111</GSM><GSM>GSM10048122</GSM><GSM>GSM10048120</GSM><GSM>GSM10048109</GSM><GSM>GSM10048118</GSM><GSM>GSM10048108</GSM><GSM>GSM10048119</GSM><GSM>GSM10048116</GSM><GSM>GSM10048117</GSM><GSM>GSM10048114</GSM><GSM>GSM10048125</GSM><GSM>GSM10048126</GSM><GSM>GSM10048115</GSM><GPL>33022</GPL><GSE>347263</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>